Prilosec OTC “Coverage Gap” Pitch Spotlights Medicare Payment Question
This article was originally published in The Tan Sheet
Executive Summary
An initiative promoting Prilosec OTC over prescription competitors to help Medicare Part D users avoid "the coverage gap" in their prescription costs may prompt a closer look at ways Medicare can pay for OTCs
You may also be interested in...
Perrigo Pursues OTC Reimbursement Opportunity In Emerging "ORx" Space
Perrigo has entered a nascent growth channel by pursuing reimbursement for OTC drugs prescribed by doctors and dispensed by pharmacists
Prilosec OTC Covered By Michigan Blues In Bid To Convert Nexium Patients
Blue Cross Blue Shield of Michigan is covering Prilosec OTC for heartburn and acid reflux disease and is seeking to convert Nexium users, reflecting increasing attention from insurers to over-the-counter drugs as vehicles for savings
Aspirin Tops Three Rx Drugs In Preventing Heart Attack – Consumers Union
Aspirin is the blood thinning agent of choice over three prescription antiplatelet medications for preventing first or repeat heart attack or stroke, according to a Consumers Union report